Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lung biopsy in immunocompromised hosts.

R L Greenman, P T Goodall, D King

    The American Journal of Medicine
    |October 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Axisymmetric Eigenmodes Excited by Alpha Particle Energy Gradients in JET D-T Plasmas.

    Physical review letters·2026
    Same author

    EMC Effect of Tritium and Helium-3 from the JLab MARATHON Experiment.

    Physical review letters·2025
    Same author

    Oral health training for carers.

    British dental journal·2023
    Same author

    An asthma collaboration to reduce childhood asthma disparities on the Navajo Nation: Trial protocol for the Community Asthma Program.

    Public health in practice (Oxford, England)·2022
    Same author

    Fusion product measurements by nuclear diagnostics in the Joint European Torus deuterium-tritium 2 campaign (invited).

    The Review of scientific instruments·2022
    Same author

    Author Correction: Development of a sensitive, quantitative assay with broad subtype specificity for detection of total HIV-1 nucleic acids in plasma and PBMC.

    Scientific reports·2022

    Lung biopsy in immunocompromised patients is valuable, especially thoracotomy, yielding treatable diagnoses in up to 65%. Complication risks are comparable to non-immunocompromised individuals.

    Area of Science:

    • Pulmonology
    • Oncology
    • Immunology

    Background:

    • Immunocompromised patients often present with undiagnosable lung lesions.
    • Accurate diagnosis is crucial for effective treatment and improved outcomes.

    Purpose of the Study:

    • To evaluate the diagnostic yield and safety of lung biopsy procedures in immunocompromised patients.
    • To compare the effectiveness of different biopsy techniques.

    Main Methods:

    • Retrospective analysis of 95 lung biopsy procedures in 78 immunocompromised patients.
    • Procedures included needle aspiration, cutting needle biopsy, and open thoracotomy.
    • Complication rates and diagnostic yields were assessed.

    Main Results:

    Related Experiment Videos

  • Treatable diagnoses were obtained in 35% of needle aspirates, 46% of cutting needle biopsies, and 65% of open thoracotomies.
  • Complication rates (bleeding, pneumothorax) were similar to non-immunocompromised patients.
  • Patients with treatable lung lesions had a higher recovery rate (70%) compared to those without specific diagnoses (25%).

    • Conclusions:

    • Lung biopsy, particularly open thoracotomy, is a valuable diagnostic tool for immunocompromised patients with undiagnosable lung lesions.
    • The procedure is generally safe, with complication rates comparable to the general population.
    • Identifying treatable lung lesions significantly improves patient outcomes.